Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
ciprofloxacin
ciprofloxacin
Formulary Duration Restrictions
Limited to 6 weeks without TLC approval.
Cell Status
Approved (oral), NFISA (inj)
Brand names:
Ciprofloxacin HYDROCHLORIDE, Cipro I.V.
Form
Strength
SOLUTION, INTRAVENOUS
10 mg/mL
TABLET, ORAL
250 mg; 500 mg
Additional Information:
JULY 2016 P&T MINUTES
Last updated:
Aug. 23, 2021
Black Box Warning:
Tendinitis; tendon rupture
FDA Drug Safety:
Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research for Cipro (ciprofloxacin hydrochloride)
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
JULY 2016 P&T MINUTES